Papers: 10 Dec 2012 - 17 Dec 2012
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling.
6.7-kbp deletion in LILRA3 (ILT6) gene is associated with later onset of the multiple sclerosis in a Polish population.
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Additive effect of prostaglandin E(2) and adenosine in mouse experimental autoimmune encephalomyelitis.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
[The chronic form of tick-born encephalitis with a clinical manifestation of disseminated encephalomyelitis (case description).]
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system.]
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
[Current possibilities of the comprehensive diagnostic assessment in the differential diagnosis of inflammation and tumors of the spine cord.]
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Clinical features of Chinese patients with multiple sclerosis with aquaporin-4 antibodies in cerebrospinal fluid but not serum.
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients.
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.